Cuando Noah Hulsman, dueño de una tienda de patinetas en Louisville, Kentucky, se enteró de que ya no calificaba para los subsidios federales que lo ayudaban a pagar su plan de salud “Oro” de la Ley de Cuidado de Salud a Bajo Precio (ACA, por sus siglas en inglés), el hombre de 37 años optó…
LISTEN: If you’re newly pregnant and not able to afford health insurance, you may qualify for Medicaid. Reporters Cara Anthony and Blake Farmer — hosts of the new series “HealthQ” — explain that every state has a program to provide coverage for pregnant people. When she noticed an unusual craving for hot dogs, Matte’a Brooks…
Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sat on a metal counter. Inside these humble-looking jars is the core of Joan Brugge’s current multiyear research project. Brugge lifted up one of the jars and gazed at it with reverence. Each jar holds…
By JEFF GOLDSMITH In the first part of our look at Arnold Ventures, we explored its business model and generous support of elite University health policy experts to further an ambitious health policy agenda. In this second part, we will explore some of the questions raised by Arnold’s aggressive approach. Zack Cooper is an Associate Professor…
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets. The post The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown…
WellTheory launched a postpartum program to help women manage autoimmune symptoms triggered by hormonal changes after childbirth. The post WellTheory Introduces Autoimmune Postpartum Program appeared first on MedCity News.
The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options. The…
Let’s say that there is a very severe disease—let’s call it horriblitis—with significant impacts on patient morbidity and mortality. The only available treatment for horriblitis is drug called BlackPill. BlackPill improves health outcomes by 1 QALY over best supportive care (BSC), but costs $500,000 over the patient’s lifetime. While not cost effective by traditional standards,…
The company’s executives say an ongoing efficiency plan will offset about $400 million of that impact and have grown their capital spending plans from last year.
At last week’s HITLAB January 2026 Symposium, Matthew Holt gave a talk about what’s wrong with primary care, how concierge care for all can fix it, and how the most advanced primary care telehealth groups are using AI now.